The chiral lithium (−)-trimethylsilylmyrtanyl amide reacts with benzonitrile yielding the chiral benzamidinate lithium ligand ([ N -trimethylsilyl][ N ‘-myrtanyl]benzamidinate Li·TMEDA (TMEDA = tetramethylethylenediamine), [N(R*)−C−N]Li. An X-ray study shows that the ligand has a distorted tetrahedral environment in which the lithium atom is arranged symmetrically between the two benzamidinate and the two TMEDA nitrogen atoms. Equimolar addition of [N(R*)−C−N]Li to TiCl 4 in THF yields [N(R*)−C−N]TiCl 3 ·THF ( 1 ). An X-ray study of 1 shows that it has an octahedral structure with the oxygen atom and one chlorine atom at the apical positions. [N(R*)−C−N] 3 ZrCl·toluene ( 2 ) can be prepared in a manner related to that employed to synthesize 1 . An X-ray study of 2 shows that it has a capped octahedral geometry with the three trimethylsilyl groups in a cis position with respect to the chlorine atom and the other three myrtanyl groups arranged on the opposite side of the chlorine. Addition of MeLi·LiBr to complex 2 yields [N(R*)−C−N] 3 ZrMe ( 3 ) which is obtained as cocrystalline with complex 2 . The X-ray structure of the cocrystalline mixture is similar to that of the chloride complex 2 exhibiting a Zr−Me distance of 2.469(10) Å. Complex 1 is an active catalyst, under pressure, for the polymerization of propylene producing elastomeric polypropylene and for the syndiotactic polymerization of styrene. Complex 2 was found to be active for the highly stereospecific polymerization of propylene.
No takes yet. Share an insight, caveat, or question.
Averbuj et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: